Jeffrey J Fletcher1, Vikas Kotagal2, Aaron Mammoser2, Mark Peterson2, Lewis B Morgenstern2, James F Burke2. 1. From the Departments of Neurosurgery (J.J.F., L.B.M.), Neurology (V.K., A.M.), Biostatistics (L.B.M.), Physical Medicine and Rehabilitation (M.P.), and the Stroke Program (L.B.M., J.F.B.), University of Michigan, Ann Arbor; and Department of Neurology, Bronson Methodist Hospital, Kalamazoo, MI (J.J.F.). fletchje@bronsonhg.org. 2. From the Departments of Neurosurgery (J.J.F., L.B.M.), Neurology (V.K., A.M.), Biostatistics (L.B.M.), Physical Medicine and Rehabilitation (M.P.), and the Stroke Program (L.B.M., J.F.B.), University of Michigan, Ann Arbor; and Department of Neurology, Bronson Methodist Hospital, Kalamazoo, MI (J.J.F.).
Abstract
BACKGROUND AND PURPOSE: Our aim was to estimate the cost-effectiveness of transferring patients with intracerebral hemorrhage from centers without specialized neurological intensive care units (neuro-ICUs) to centers with neuro-ICUs. METHODS: Decision analytic models were developed for the lifetime horizons. Model inputs were derived from the best available data, informed by a variety of previous cost-effectiveness models of stroke. The effect of neuro-ICU care on functional outcomes was modeled in 3 scenarios. A favorable outcomes scenario was modeled based on the best observational data and compared with moderately favorable and least-favorable outcomes scenarios. Health benefits were measured in quality-adjusted life years (QALYs), and costs were estimated from a societal perspective. Costs were combined with QALYs gained to generate incremental cost-effectiveness ratios. One-way sensitivity analysis and Monte Carlo simulations were performed to test robustness of the model assumptions. RESULTS: Transferring patients to centers with neuro-ICUs yielded an incremental cost-effectiveness ratio for the lifetime horizon of $47,431 per QALY, $91,674 per QALY, and $380,358 per QALY for favorable, moderately favorable, and least-favorable scenarios, respectively. Models were robust at a willingness-to-pay threshold of $100,000 per QALY, with 95.5%, 75.0%, and 2.1% of simulations below the threshold for favorable, moderately favorable, and least-favorable scenarios, respectively. CONCLUSIONS: Transferring patients with intracerebral hemorrhage to centers with specialized neuro-ICUs is cost-effective if observational estimates of the neuro-ICU-based functional outcome distribution are accurate. If future work confirms these functional outcome distributions, then a strong societal rationale exists to build systems of care designed to transfer intracerebral hemorrhage patients to specialized neuro-ICUs.
BACKGROUND AND PURPOSE: Our aim was to estimate the cost-effectiveness of transferring patients with intracerebral hemorrhage from centers without specialized neurological intensive care units (neuro-ICUs) to centers with neuro-ICUs. METHODS: Decision analytic models were developed for the lifetime horizons. Model inputs were derived from the best available data, informed by a variety of previous cost-effectiveness models of stroke. The effect of neuro-ICU care on functional outcomes was modeled in 3 scenarios. A favorable outcomes scenario was modeled based on the best observational data and compared with moderately favorable and least-favorable outcomes scenarios. Health benefits were measured in quality-adjusted life years (QALYs), and costs were estimated from a societal perspective. Costs were combined with QALYs gained to generate incremental cost-effectiveness ratios. One-way sensitivity analysis and Monte Carlo simulations were performed to test robustness of the model assumptions. RESULTS: Transferring patients to centers with neuro-ICUs yielded an incremental cost-effectiveness ratio for the lifetime horizon of $47,431 per QALY, $91,674 per QALY, and $380,358 per QALY for favorable, moderately favorable, and least-favorable scenarios, respectively. Models were robust at a willingness-to-pay threshold of $100,000 per QALY, with 95.5%, 75.0%, and 2.1% of simulations below the threshold for favorable, moderately favorable, and least-favorable scenarios, respectively. CONCLUSIONS: Transferring patients with intracerebral hemorrhage to centers with specialized neuro-ICUs is cost-effective if observational estimates of the neuro-ICU-based functional outcome distribution are accurate. If future work confirms these functional outcome distributions, then a strong societal rationale exists to build systems of care designed to transfer intracerebral hemorrhagepatients to specialized neuro-ICUs.
Authors: G P Samsa; R A Reutter; G Parmigiani; M Ancukiewicz; P Abrahamse; J Lipscomb; D B Matchar Journal: J Clin Epidemiol Date: 1999-03 Impact factor: 6.437
Authors: Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo Journal: Stroke Date: 2010-07-22 Impact factor: 7.914
Authors: E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa Journal: Stroke Date: 2012-05-03 Impact factor: 7.914
Authors: Jeannette Hofmeijer; H Bart van der Worp; L Jaap Kappelle; Sara Eshuis; Ale Algra; Jacoba P Greving Journal: Stroke Date: 2013-08-13 Impact factor: 7.914
Authors: Brian S Katz; Opeolu Adeoye; Heidi Sucharew; Joseph P Broderick; Jason McMullan; Pooja Khatri; Michael Widener; Kathleen S Alwell; Charles J Moomaw; Brett M Kissela; Matthew L Flaherty; Daniel Woo; Simona Ferioli; Jason Mackey; Sharyl Martini; Felipe De Los Rios la Rosa; Dawn O Kleindorfer Journal: Stroke Date: 2017-07-12 Impact factor: 7.914
Authors: Floris H B M Schreuder; Mirre Scholte; Marike J Ulehake; Lotte Sondag; Maroeska M Rovers; Ruben Dammers; Catharina J M Klijn; Janneke P C Grutters Journal: Front Neurol Date: 2022-06-02 Impact factor: 4.086
Authors: Farhaan S Vahidy; Ellie G Meyer; Arvind B Bambhroliya; Jennifer R Meeks; Charles E Begley; Tzu-Ching Wu; Jon E Tyson; Charles C Miller; Ritvij Bowry; Wamda O Ahmed; Gretchel A Gealogo; Louise D McCullough; Steven Warach; Sean I Savitz Journal: BMC Neurol Date: 2018-03-21 Impact factor: 2.474
Authors: Lesli E Skolarus; Anne E Sales; Marc A Zimmerman; Casey L Corches; Zach Landis-Lewis; Maria Cielito Robles; A Camille McBride; Narmeen Rehman; Alina Oliver; Nishat Islam; Mellanie V Springer; Alison O'Brien; Sarah Bailey; Lewis B Morgenstern; William J Meurer; James F Burke Journal: Implement Sci Date: 2019-03-07 Impact factor: 7.327
Authors: Kori Sauser Zachrison; Emily Aaronson; Sadiqa Mahmood; Jonathan Rosand; Anand Viswanathan; Lee H Schwamm; Joshua N Goldstein Journal: Stroke Vasc Neurol Date: 2019-11-28
Authors: Daojun Hong; Dana Stradling; Cyrus K Dastur; Yama Akbari; Leonid Groysman; Lama Al-Khoury; Jefferson Chen; Steven L Small; Wengui Yu Journal: Front Neurol Date: 2017-05-03 Impact factor: 4.003